| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/27/2006 | WO2005113747A3 Multicellular tissue and organ culture systems |
| 04/27/2006 | WO2005085421A3 Treatment of spinal conditions |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088606 Methods and compositions for use in perfusion applications |
| 04/27/2006 | US20060088601 Synthetic bone substitute material |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088514 Formulation comprising a bacterial strain |
| 04/27/2006 | US20060088513 Antiallergic composition |
| 04/27/2006 | US20060088511 Cancer therapy sensitizer |
| 04/27/2006 | US20060088510 Promotes the growth and differentiation of cells; attached therapeutic agents can be used to promote this process and the gel along with the growing cells can be implanted at a site in vivo where tissue repair is needed; membranes can be used for culturing cells in vitro; delivering drugs in vitro |
| 04/27/2006 | US20060088509 Isolated clk-1 -/- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | US20060088507 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/27/2006 | US20060088506 Process for producing cartilage cells for transplantation |
| 04/27/2006 | US20060088505 Hair follicle mesenchymal stem cells and use thereof |
| 04/27/2006 | CA2584738A1 Generation and differentiation of adult stem cell lines |
| 04/27/2006 | CA2583138A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650295A1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1649879A2 Decellularized tissue |
| 04/26/2006 | EP1649872A1 Sheet for guiding regeneration of mesenchymal tissue and production method thereof |
| 04/26/2006 | EP1649863A1 Composition for lowering serum uric acid level |
| 04/26/2006 | EP1649862A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 04/26/2006 | EP1649760A1 Composition containing lactic acid bacterium producing equol |
| 04/26/2006 | EP1649290A2 Stable compositions for measuring human natriuretic peptides |
| 04/26/2006 | EP1649013A2 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 04/26/2006 | EP1649012A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 04/26/2006 | EP1649008A2 Aligned scaffolds for improved myocardial regeneration |
| 04/26/2006 | EP1649007A2 Methods for ex-vivo expanding stem/progenitor cells |
| 04/26/2006 | EP1649003A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 04/26/2006 | EP1648533A1 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 04/26/2006 | EP1648520A1 Compounds and methods for downregulating the effects of tgf-beta |
| 04/26/2006 | EP1648508A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
| 04/26/2006 | EP1648507A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 04/26/2006 | EP1648493A2 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor |
| 04/26/2006 | EP1648483A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/26/2006 | EP1648480A2 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles |
| 04/26/2006 | EP1648479A2 Therapeutic use of lipids extracted from mother of pearl |
| 04/26/2006 | EP1648478A1 Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| 04/26/2006 | EP1648477A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 04/26/2006 | EP1648463A2 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 04/26/2006 | EP1648397A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 04/26/2006 | EP1648380A2 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1056779B1 Method for producing a factor viii/von willebrand factor complex |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 04/26/2006 | EP0811057B1 Viral preparations, vectors, immunogens, and vaccines |
| 04/26/2006 | CN1764481A Cellular preparation |
| 04/26/2006 | CN1764476A Composition and method for the treatment and prevention of enteric bacterial infections |
| 04/26/2006 | CN1764372A Autologous or homologous coagulant produced from anticoagulated whole blood |
| 04/26/2006 | CN1763177A Novel bacillus and its separation method and application |
| 04/26/2006 | CN1762528A Non-linear vibration critical method for extraction of China forest frog complete nutrition ingredients |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1762487A IL-2 precursor liposome and its preparation method |
| 04/26/2006 | CN1762486A Use of cerebrosid-kinin in preparation of medicine for preventing and treating peripheral nerve disease |
| 04/26/2006 | CN1762481A Foot underside plaster for keeping fitness |
| 04/26/2006 | CN1762478A Nebula removing pills |
| 04/26/2006 | CN1762476A Compound formulation for treating lumbago and preparation process thereof |
| 04/26/2006 | CN1762454A Chinese traditional medicinal composition for treating psoriasis |
| 04/26/2006 | CN1762448A Chinese herbal preparation for killing fungus of fish, shrimp and crab |
| 04/26/2006 | CN1762437A Bolus for treating rheumatic or rheumatoid arthritis and its preparation method |
| 04/26/2006 | CN1762433A Novel medicinal formula for treating bone fracture and its preparation method |
| 04/26/2006 | CN1762423A Foot smell removing Chinese medicine |
| 04/26/2006 | CN1762394A Trogopterus dung-containing pain-relieving pill formula and its preparation method |
| 04/26/2006 | CN1762391A Cow colostrums and lentinus edodes extracts composition, its preparation method and application |
| 04/26/2006 | CN1762390A Burn and boil medicine and its preparation method |
| 04/26/2006 | CN1762388A Tasty, refreshing, sterilizing, yin-nourishing health care product or drug formula and preparation method thereof |
| 04/26/2006 | CN1762387A Aquaculture creature disease controlling compound vaccine and its preparation method |
| 04/26/2006 | CN1762386A Bone density-increasing and senility-postponing capsule formulation |
| 04/26/2006 | CN1762385A Eye gel or in-situ gel and preparation method thereof |
| 04/26/2006 | CN1762384A Bear gall pill formula and its preparation method |
| 04/26/2006 | CN1762383A Preparation process of hepatic cell growth promotion protein and its injection preparation method |
| 04/26/2006 | CN1253551C Genetically modified tumor-targeted bacteria with reduced virulence |
| 04/26/2006 | CN1253208C Use of antibodies against CD2O for treatment of graft versus host disease |
| 04/26/2006 | CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 04/26/2006 | CN1253202C Traditional chinese medicine for treating postpartum diseases |
| 04/26/2006 | CN1253200C Sparganium qijia decoction for treating cancer |
| 04/26/2006 | CN1253197C Medicine for treating rheumatoid and rheumatic arthritis and preparation method thereof |
| 04/26/2006 | CN1253195C Anti-age capsule of traditional Chinese medicine and preparation method |
| 04/26/2006 | CN1253193C Decolouring technology for compound Chinese herbal medicine |
| 04/26/2006 | CN1253188C Medicine for treating hypertension and its preparing process |
| 04/26/2006 | CN1253186C Primordial qi strengthening plaster |
| 04/26/2006 | CN1253181C Pure Chinese medicine preparation for treating angiitis and preparation process thereof |
| 04/26/2006 | CN1253180C Externally applied Chinese medicinal plaster for treating bone pain |
| 04/26/2006 | CN1253179C Drug for treating ischemic necrosis of femoral head |
| 04/26/2006 | CN1253178C Comminuted fracture treating bolus |
| 04/26/2006 | CN1253176C Formulation of skin protecting and health care capsule |
| 04/26/2006 | CN1253174C Oral liquor for tonify kidney and invigorate yang |
| 04/26/2006 | CN1253168C Medicinal composition for treating chronic obstructive emphysema and preparation method thereof |
| 04/26/2006 | CN1253166C Medicine for treating gastric ulcer, chronic gastritis and dyspepsia |
| 04/26/2006 | CN1253163C Medicinal composition for preventing and treating hyperplasia of prostate and preparation method thereof |
| 04/26/2006 | CN1253161C Medicine for treating cerebrovascular disease |
| 04/26/2006 | CN1253159C Health product of compound propolis and preparing method |
| 04/26/2006 | CN1253158C Luminescent bio-element and preparation process thereof |
| 04/26/2006 | CN1253153C Use of trivalency chromium in preparation of drug against allergic rhinitis |